3-hydroxy-3-methylglutaryl-coenzyme a has been researched along with ubiquinone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Himberg, JJ; Jokelainen, K; Laaksonen, R; Sahi, T; Tikkanen, MJ | 1 |
| Baker, SK; Tarnopolsky, MA | 1 |
1 review(s) available for 3-hydroxy-3-methylglutaryl-coenzyme a and ubiquinone
| Article | Year |
|---|---|
Statin-associated neuromyotoxicity.
Topics: Acyl Coenzyme A; Adverse Drug Reaction Reporting Systems; Cholesterol; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Muscular Diseases; Peripheral Nervous System Diseases; Rhabdomyolysis; Terpenes; Ubiquinone | 2005 |
1 trial(s) available for 3-hydroxy-3-methylglutaryl-coenzyme a and ubiquinone
| Article | Year |
|---|---|
Decreases in serum ubiquinone concentrations do not result in reduced levels in muscle tissue during short-term simvastatin treatment in humans.
Topics: Acyl Coenzyme A; Adult; Anticholesteremic Agents; Cholesterol; Chromatography, High Pressure Liquid; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Muscles; Simvastatin; Ubiquinone | 1995 |